Multiple endocrine neoplasias type 2B and RET proto-oncogene.

Italian Journal of Pediatrics
G MartuccielloSergio Bernasconi


Multiple Endocrine Neoplasia type 2B (MEN 2B) is an autosomal dominant complex oncologic neurocristopathy including medullary thyroid carcinoma, pheochromocytoma, gastrointestinal disorders, marphanoid face, and mucosal multiple ganglioneuromas. Medullary thyroid carcinoma is the major cause of mortality in MEN 2B syndrome, and it often appears during the first years of life. RET proto-oncogene germline activating mutations are causative for MEN 2B. The 95% of MEN 2B patients are associated with a point mutation in exon 16 (M918/T). A second point mutation at codon 883 has been found in 2%-3% of MEN 2B cases. RET proto-oncogene is also involved in different neoplastic and not neoplastic neurocristopathies. Other RET mutations cause MEN 2A syndrome, familial medullary thyroid carcinoma, or Hirschsprung's disease. RET gene expression is also involved in Neuroblastoma. The main diagnosis standards are the acetylcholinesterase study of rectal mucosa and the molecular analysis of RET. In our protocol the rectal biopsy is, therefore, the first approach. RET mutation detection offers the possibility to diagnose MEN 2B predisposition at a pre-clinical stage in familial cases, and to perform an early total prophylactic thyroidectomy. Th...Continue Reading


Feb 1, 1977·European Journal of Clinical Investigation·M Telenius-BergB Wasthed
Jan 1, 1992·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·H DralleE G Brabant
Dec 1, 1995·Surgery·D S O'RiordainJ A van Heerden
Jul 1, 1995·The Journal of Clinical Endocrinology and Metabolism·L M Mulligan, B A Ponder
Oct 1, 1994·European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [et Al] = Zeitschrift Für Kinderchirurgie·G MartuccielloV Jasonni
Aug 1, 1993·Current Opinion in Genetics & Development·M Bronner-Fraser
Nov 15, 1993·Biochemical and Biophysical Research Communications·I CeccheriniG Romeo
Jan 1, 1996·Journal of Pediatric Surgery·M A SkinnerS A Wells
Sep 1, 1996·Journal of Medical Genetics·P J Morrison, N C Nevin
Jul 1, 1997·The American Journal of Medicine·H M HeshmatiG W Sizemore
Jul 29, 1998·Journal of Internal Medicine·G RomeoG Martucciello
Sep 4, 1998·Molecular and Cellular Probes·A E PeastonG M Marshall
Feb 18, 1999·Journal of Pediatric Surgery·M A IlerJ F Sotos
Oct 16, 1999·American Journal of Human Genetics·G FitzeD Roesner
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·S BolkA Chakravarti
Aug 5, 2000·Journal of Pediatric Surgery·G MartuccielloV Jasonni
Nov 10, 2000·Journal of Medical Genetics·J R Hansford, L M Mulligan
May 18, 2001·Surgical Oncology·N C Lee, J A Norton
Nov 6, 2001·Journal of Medical Genetics·J Amiel, S Lyonnet
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·M L BrandiS J Marx
Jan 15, 2002·The Journal of Clinical Endocrinology and Metabolism·Fred H MenkoCornelis J M Lips
Apr 16, 2002·Nature Genetics·Stacey B GabrielAravinda Chakravarti
Sep 6, 2002·American Journal of Human Genetics·Paola GriseriIsabella Ceccherini
Mar 1, 1964·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·M J KARNOVSKY, L ROOTS
Feb 7, 2007·Der Pathologe·G MartuccielloU Magrini

❮ Previous
Next ❯


Sep 18, 2014·Birth Defects Research. Part C, Embryo Today : Reviews·Parinya Noisa, Taneli Raivio
Oct 25, 2012·Case Reports in Medicine·Banafshe ShahnazariAbdolreza Babamahmoodi
Jul 13, 2017·Endocrine-related Cancer·Frederic CastinettiSteven G Waguespack
Oct 4, 2017·Pediatrics in Review·Matthias KochmannSheila Perez-Colon
Nov 8, 2019·Radiographics : a Review Publication of the Radiological Society of North America, Inc·T Shawn SatoYutaka Sato

❮ Previous
Next ❯

Methods Mentioned

prophylactic surgery

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.